Digest Network Come funziona
Network
/
Società
Al
Non verificato

Alpha Cognition Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMercato azionarioSalute

45 comunicati stampa

Guarda tutti i comunicati
28/04/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Alpha Cognition (Nasdaq: ACOG) to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, May 14, 2026
Fonte
Alpha Cognition Inc.
Emittente
Business Wire
1.00
0
20/04/2026
Biotecnologia
Farmaceutica
Salute
Mercato del lavoro
Alpha Cognition Strengthens Its Board of Directors with Appointment of Bethany Sensenig
Fonte
Alpha Cognition Inc.
Emittente
Business Wire
1.00
0
16/04/2026
Biotecnologia
Farmaceutica
Salute
Mercato azionario
Finanza
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Alpha Cognition Inc.
Emittente
Business Wire
1.00
0
01/04/2026
Biotecnologia
Sanità
Psichiatria
Salute
Farmaceutica
Industria
Alpha Cognition Receives Issued U.S. Patent for ALPHA-1062 for Treatment of Traumatic Brain Injury
Fonte
Alpha Cognition Inc.
Emittente
Business Wire
1.00
0
26/03/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Mercato del lavoro
Eventi
Industria
Salute
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update
Fonte
Alpha Cognition Inc.
Emittente
Business Wire
1.00
0
13/03/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Alpha Cognition (Nasdaq: ACOG) to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, March 26, 2026
Fonte
Alpha Cognition Inc.
Emittente
Business Wire
1.00
0
10/03/2026
Eventi
Industria
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Alpha Cognition to Present New Clinical on ZUNVEYL® (Benzgalantamine) at Multiple Upcoming Alzheimer’s Association International Conferences
Fonte
Alpha Cognition Inc.
Emittente
Business Wire
1.00
0
25/02/2026
Industria
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Alpha Cognition Announces First Patient Enrolled in BEACON Real-World Effectiveness Study
Fonte
Alpha Cognition Inc.
Emittente
Business Wire
1.00
0
18/02/2026
Biotecnologia
Farmaceutica
Salute
Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens
Fonte
Alpha Cognition Inc.
Emittente
Business Wire
1.00
0
01/12/2025
Web e Social Network
Eventi
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners
Fonte
Alpha Cognition Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0